A study looking at Radspherin for ovarian cancer

This study is looking at a type of radiopharmaceutical therapy (also called radioisotope therapy) called Radspherin after surgery to remove ovarian cancer.

It is open to women who have one of the following:

• ovarian cancer

• fallopian tube cancer

• primary peritoneal cancer

It is for women whose cancer has spread to the space where the stomach, liver, kidneys and other organs are. And who are due to have chemotherapy followed by surgery.

You pronounce Radspherin as RAD-sfer-in.